Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.

Katsuyoshi Matsuoka Tadakazu Hisamatsu Hyo Jong Kim Byong Duk Ye Shoko Arai Masato HoshiHirotoshi YuasaJunichi TabiraShigeyuki Toyoizumi Nanzhi ShiJoon-Suk WooToshifumi Hibi

Published in: Journal of gastroenterology and hepatology (2022)

The HZ IR in East Asian patients was numerically higher versus the global study population; excluding HZ, tofacitinib safety and efficacy were consistent with the global study population.

Keyphrases

ulcerative colitis
rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
combination therapy